Metrics
- Price
- $43.84
- Market Cap $M
- 7,307
- Rel Volume
- 0.67
- Vol Up 2W
- 33.3%
- Vol Trend 2W
- -46.2%
- 1D
- -1.0%
- 1W
- +1.1%
- 1M
- +14.5%
- 1M Slope
- +20.4%
- 6M Range
- 62.8%
- Score
- 73.3
- Sharp
- 2.6
Volume
Profile
Biopharmaceutical company developing medicines for addiction, schizophrenia, depression, and other central nervous system and neuroscience-related disorders.
Healthcare
Pharmaceuticals
Biotech